Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $408,300.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00. Following the completion of the transaction, the president now owns 1,606,097 shares in the company, valued at approximately $21,858,980.17. This represents a 1.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, November 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.35, for a total transaction of $340,500.00.

Alignment Healthcare Stock Performance

Shares of NASDAQ:ALHC traded up $0.03 during mid-day trading on Friday, reaching $14.58. 1,873,020 shares of the company traded hands, compared to its average volume of 1,888,102. The company's 50 day moving average price is $11.92 and its 200-day moving average price is $10.71. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The firm has a market cap of $2.79 billion, a PE ratio of -18.94 and a beta of 1.45. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $14.79.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.14). The business had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. Alignment Healthcare's revenue for the quarter was up 51.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.19) EPS. On average, equities analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Rhumbline Advisers lifted its holdings in shares of Alignment Healthcare by 13.3% in the second quarter. Rhumbline Advisers now owns 137,296 shares of the company's stock worth $1,074,000 after buying an additional 16,083 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Alignment Healthcare by 16.8% in the 2nd quarter. Renaissance Technologies LLC now owns 1,565,800 shares of the company's stock worth $12,245,000 after purchasing an additional 225,000 shares in the last quarter. Hood River Capital Management LLC boosted its holdings in shares of Alignment Healthcare by 6.4% during the 2nd quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company's stock valued at $24,294,000 after purchasing an additional 185,854 shares during the last quarter. AQR Capital Management LLC purchased a new position in shares of Alignment Healthcare during the second quarter valued at about $1,512,000. Finally, Deerfield Management Company L.P. Series C lifted its position in shares of Alignment Healthcare by 31.8% in the second quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company's stock worth $85,250,000 after buying an additional 2,630,788 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have commented on ALHC. Stifel Nicolaus lifted their target price on Alignment Healthcare from $14.00 to $16.00 and gave the stock a "buy" rating in a report on Tuesday. Barclays boosted their target price on Alignment Healthcare from $7.00 to $8.00 and gave the stock an "underweight" rating in a research report on Wednesday, October 30th. UBS Group raised their price target on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a "neutral" rating in a report on Wednesday, October 30th. KeyCorp initiated coverage on shares of Alignment Healthcare in a report on Friday, October 11th. They set a "sector weight" rating for the company. Finally, Stephens restated an "overweight" rating and issued a $17.00 target price on shares of Alignment Healthcare in a report on Thursday, January 2nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Alignment Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.